A. Lenauer

592 total citations
13 papers, 444 citations indexed

About

A. Lenauer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, A. Lenauer has authored 13 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Hepatology. Recurrent topics in A. Lenauer's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and Gastric Cancer Management and Outcomes (5 papers). A. Lenauer is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and Gastric Cancer Management and Outcomes (5 papers). A. Lenauer collaborates with scholars based in Austria, Germany and Netherlands. A. Lenauer's co-authors include Gabriela Kornek, Werner Scheithauer, D. Depisch, Markus Raderer, Bruno Schneeweiß, B. Schüll, H. Ulrich-Pur, Fritz Lang, Wolfgang Fiebiger and Katharina Schmid and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

A. Lenauer

13 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Lenauer Austria	9	355	240	210	99	28	13	444
Friedrich Laengle Austria	10	214 0.6×	190 0.8×	274 1.3×	119 1.2×	27 1.0×	26	407
Seigo Yukisawa Japan	12	165 0.5×	182 0.8×	152 0.7×	65 0.7×	16 0.6×	27	353
Silvana Leo Italy	12	250 0.7×	87 0.4×	70 0.3×	63 0.6×	30 1.1×	17	358
Satoshi Hatano Japan	11	178 0.5×	129 0.5×	213 1.0×	39 0.4×	48 1.7×	49	355
Sanaz Ainechi United States	9	271 0.8×	177 0.7×	226 1.1×	25 0.3×	23 0.8×	18	430
J D K Munting Netherlands	6	225 0.6×	95 0.4×	169 0.8×	76 0.8×	38 1.4×	11	323
Abdul Hamid El Chafic United States	9	212 0.6×	198 0.8×	305 1.5×	24 0.2×	8 0.3×	25	406
D. Avenin France	5	291 0.8×	221 0.9×	295 1.4×	33 0.3×	32 1.1×	9	400
V. Bourgeois France	6	89 0.3×	91 0.4×	174 0.8×	14 0.1×	20 0.7×	9	220
Carla Hannig Germany	9	281 0.8×	76 0.3×	202 1.0×	16 0.2×	16 0.6×	28	311

Countries citing papers authored by A. Lenauer

Since Specialization

Citations

This map shows the geographic impact of A. Lenauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lenauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lenauer more than expected).

Fields of papers citing papers by A. Lenauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lenauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lenauer. The network helps show where A. Lenauer may publish in the future.

Co-authorship network of co-authors of A. Lenauer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lenauer. A scholar is included among the top collaborators of A. Lenauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lenauer. A. Lenauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Santol, Jonas, Birgit Gruenberger, A. Lenauer, et al.. (2024). Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial. Cancers. 16(5). 857–857. 1 indexed citations

Gruenberger, Thomas, Josef Thaler, Wolfgang Eisterer, et al.. (2012). PD-0004 Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer; A Multicenter, Single Arm Phase I/II Trial: Asso Lm1. Annals of Oncology. 23. iv19–iv20. 1 indexed citations

Gruenberger, Thomas, Friedrich Laengle, J. Thaler, et al.. (2010). Pre- and postoperative chemotherapy including bevacizumab in potentially curable metastatic colorectal cancer: A multicenter, single-arm phase II trial—Results of ASSO LM1.. Journal of Clinical Oncology. 28(15_suppl). e14032–e14032. 1 indexed citations

Vormittag, Laurenz, Gabriela Kornek, A. Lenauer, et al.. (2007). UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer – a retrospective analysis. Anti-Cancer Drugs. 18(6). 709–712. 14 indexed citations

Schüll, B., Gabriela Kornek, Katharina Schmid, et al.. (2003). Effective Combination Chemotherapy with Bimonthly Docetaxel and Cisplatin with or without Hematopoietic Growth Factor Support in Patients with Advanced Gastroesophageal Cancer. Oncology. 65(3). 211–217. 14 indexed citations

Schmid, Katharina, Gabriela Kornek, B. Schüll, et al.. (2003). Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed. Oncology Research and Treatment. 26(3). 255–258. 20 indexed citations

Scheithauer, Werner, Gabriela Kornek, Markus Raderer, et al.. (2003). Randomized Multicenter Phase II Trial of Two Different Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer. Journal of Clinical Oncology. 21(7). 1307–1312. 141 indexed citations

Schüll, B., Gabriela Kornek, Katharina Schmid, et al.. (2002). Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen. Oncology Research and Treatment. 25(4). 358–362. 4 indexed citations

Kornek, Gabriela, Markus Raderer, B. Schüll, et al.. (2002). Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer. British Journal of Cancer. 86(12). 1858–1863. 32 indexed citations

10.

Scheithauer, Werner, Gabriela Kornek, Markus Raderer, et al.. (2002). Randomized Multicenter Phase II Trial of Oxaliplatin Plus Irinotecan Versus Raltitrexed as First-Line Treatment in Advanced Colorectal Cancer. Journal of Clinical Oncology. 20(1). 165–172. 21 indexed citations

11.

Scheithauer, Werner, Gabriela Kornek, B. Schuell, et al.. (2001). Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy. Annals of Oncology. 12(5). 709–714. 32 indexed citations

12.

Ulrich-Pur, H., Gabriela Kornek, Wolfgang Fiebiger, et al.. (2001). Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy. Annals of Oncology. 12(9). 1269–1272. 14 indexed citations

13.

Penz, M., Gabriela Kornek, Markus Raderer, et al.. (2001). Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Annals of Oncology. 12(2). 183–186. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact